
John P. Sfakianos, MD, discusses how ctDNA can be optimally integrated into bladder cancer clinical trials.
Urologists from the University of North Carolina share insights into key advancements across the field of urologic oncology.
The field of urologic oncology is rapidly evolving. Urology Times® recently spoke with several urologists from the University of North Carolina, who shared insights into key advancements across the field.
Specifically, you'll hear from:






